 patents generic India Novartis companies Glivec sales India's Supreme court India Cancer law appeal precedent pharmaceutical companies Cipla Swiss price markets innovation medical diseases treatment chronic myeloid leukaemia medicine Anand Grover practice evergreening Supreme Court Doctors Without Borders who patent cliff profits AFP news agency novelty firms protection first exclusive right Pratibha Singh Bombay Stock Exchange